Boston Scientific Announces Update on LOTUS Edge™ Aortic Valve System
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Boston Scientific (BSX) PT Lowered to $30 at Stifel Following Lotus Delay
November 29, 2017 1:42 PM ESTStifel lowered its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $32.00) while maintaining a Buy rating following the company's confirmation of another Lotus EDGE (TAVR) US/EU delay.
On this mornings call, BSX reaffirmed a strong commitment to Lotus, although... More
